Genmab — December 2015
-
plessner foretrækker POM
-
nu kommer det dummeste spm, jeg længe har hørt
-
hahaha - studies only become expensive when you identify a winner
-
CLASSIC!!!
-
Det er fandme genial service. Hvis man stiller et spørgsmål sender Rachel en mail med svaret hvis ikke de har tid til det. !
-
solsen - assuming dara will not become a winner
-
Den servive har Zealand Pharma også.
-
service..Begge firmaer har Q&A med PI.
-
Så er vi færdige
-
Vi klapper.
-
Så mangler vi bare analytikeropjusteringer på stribe i morgen
-
det var ikke mange spm de tog fra CC
-
Det må siges.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind